Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15% of brain tumours known as meningiomas, a finding that could lead to the first effective drug treatments for these tumours, scientists from Dana-Farber Cancer Institute and the Broad Institute reported in the journal Nature Genetics. Read more here.
Study mentioned: Brastianos PK, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013 Jan 20. [Epub ahead of print] PMID: 23334667
No comments:
Post a Comment